Feigning Symptoms to Obtain Prescription Stimulants: A Vignette-Based Study on Its Conditions
This vignette-based study examined the willingness to feign symptoms to obtain a prescription following an analysis on who might use prescription stimulants to enhance performance (N = 3,468). It experimentally manipulated three factors: the social disapproval of prescription stimulant use for enhan...
1. VerfasserIn: | |
---|---|
Beteiligte: | ; ; |
Medienart: | Elektronisch Aufsatz |
Sprache: | Englisch |
Veröffentlicht: |
29.11.2021
|
In: |
Journal of drug issues
Jahr: 2022, Band: 52, Heft: 2, Seiten: 225-249 |
Online-Zugang: |
Volltext (lizenzpflichtig) |
Journals Online & Print: | |
Verfügbarkeit prüfen: | HBZ Gateway |
Schlagwörter: |
MARC
LEADER | 00000caa a2200000 c 4500 | ||
---|---|---|---|
001 | 1795543825 | ||
003 | DE-627 | ||
005 | 20240327221929.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220315s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/00220426211055433 |2 doi | |
035 | |a (DE-627)1795543825 | ||
035 | |a (DE-599)KXP1795543825 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 2,1 |2 ssgn | ||
100 | 1 | |a van Veen, Floris |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Feigning Symptoms to Obtain Prescription Stimulants: A Vignette-Based Study on Its Conditions |
264 | 1 | |c 29.11.2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a This vignette-based study examined the willingness to feign symptoms to obtain a prescription following an analysis on who might use prescription stimulants to enhance performance (N = 3,468). It experimentally manipulated three factors: the social disapproval of prescription stimulant use for enhancement purposes, the physicians’ diagnostic efforts, and the medical condition (attention-deficit/hyperactivity disorder and narcolepsy); respondent characteristics of self-control, personal morality, and self-efficacy were also measured. Our results showed that social disapproval of prescription drug use, a personal morality that disapproves of drug use, high self-control, and high self-efficacy were negatively associated with the willingness to use. Willingness increased especially in situations of social approval when there was a stronger personal approval of drug use, or surprisingly when physicians’ diagnostic efforts were higher. The feigning willingness was lower in situations of social disapproval and when personal morality disapproved of feigning. Thus, personal and situational characteristics are relevant to understand both behaviors. | ||
650 | 4 | |a Malignering | |
650 | 4 | |a Narcolepsy | |
650 | 4 | |a Attention-deficit/hyperactivity disorder | |
650 | 4 | |a Factorial Survey Design | |
650 | 4 | |a cognitive enhancement | |
650 | 4 | |a Personal Morality | |
650 | 4 | |a Injunctive norms | |
650 | 4 | |a Nonmedical use of prescription stimulants | |
650 | 4 | |a feigning symptoms | |
700 | 1 | |a Sattler, Sebastian |e VerfasserIn |0 (DE-588)1274392098 |0 (DE-627)1824168101 |4 aut | |
700 | 1 | |a Mehlkop, Guido |d 1972- |e VerfasserIn |0 (DE-588)173564488 |0 (DE-627)674599209 |0 (DE-576)185902111 |4 aut | |
700 | 1 | |a Hasselhorn, Fabian |e VerfasserIn |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of drug issues |d Thousand Oaks, Calif. : Sage, 1971 |g 52(2022), 2, Seite 225-249 |h Online-Ressource |w (DE-627)331258277 |w (DE-600)2051257-0 |w (DE-576)260774243 |x 1945-1369 |7 nnas |
773 | 1 | 8 | |g volume:52 |g year:2022 |g number:2 |g pages:225-249 |
856 | 4 | 0 | |u https://doi.org/10.1177/00220426211055433 |x Resolving-System |z lizenzpflichtig |3 Volltext |
935 | |a mkri | ||
951 | |a AR | ||
ELC | |a 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 4089007259 | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 1795543825 | ||
LOK | |0 005 20220315051545 | ||
LOK | |0 008 220315||||||||||||||||ger||||||| | ||
LOK | |0 035 |a (DE-2619)KrimDok#2022-03-12#0AD0569397BDCB5F9268F161C15DDE51F18BF7A4 | ||
LOK | |0 040 |a DE-2619 |c DE-627 |d DE-2619 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-2619 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 935 |a zota | ||
ORI | |a SA-MARC-krimdoka001.raw |